Suppr超能文献

综述文章:肝硬化患者腹水及相关并发症的管理

Review article: Management of ascites and associated complications in patients with cirrhosis.

作者信息

Kuiper J J, de Man R A, van Buuren H R

机构信息

Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:183-93. doi: 10.1111/j.1365-2036.2007.03482.x.

Abstract

BACKGROUND

Ascites is the most common complication of cirrhosis, associated with an expected survival below 50% after 5 years. Prognosis is particularly poor for patients with refractory ascites and for those developing complications, including spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome (HRS).

AIM

To provide an evidence-based overview of the pathophysiology, diagnosis and clinical management of ascites secondary to liver cirrhosis.

METHODS

Review based on relevant medical literature.

RESULTS

Portal hypertension, splanchnic vasodilatation and renal sodium retention are fundamental in the pathophysiology of ascites formation. The SAAG (serum-ascites albumin gradient) allows reliable assessment of the cause of ascites. The majority of cirrhotic patients with ascites can be managed with dietary sodium restriction in combination with diuretic agents. Large volume paracentesis with albumin suppletion and TIPS are therapeutic options in patients with refractory ascites. Prophylactic antibiotics for SBP should be given in certain patient populations.

CONCLUSIONS

Recent advances in the diagnosis and treatment of ascites and associated complications have improved the medical management and poor prognosis of patients with these manifestations of advanced liver disease. Early diagnosis, adequate treatment and focus on prevention of complications remain essential as well as timely referral for liver transplantation.

摘要

背景

腹水是肝硬化最常见的并发症,5年后预期生存率低于50%。难治性腹水患者以及出现包括自发性细菌性腹膜炎(SBP)和肝肾综合征(HRS)等并发症的患者预后尤其差。

目的

对肝硬化继发性腹水的病理生理学、诊断及临床管理提供基于证据的概述。

方法

基于相关医学文献进行综述。

结果

门静脉高压、内脏血管扩张和肾钠潴留是腹水形成病理生理学的基本因素。血清腹水白蛋白梯度(SAAG)有助于可靠评估腹水病因。大多数肝硬化腹水患者可通过限制饮食钠摄入并联合利尿剂进行管理。大量放腹水加白蛋白补充以及经颈静脉肝内门体分流术(TIPS)是难治性腹水患者的治疗选择。特定患者群体应给予SBP预防性抗生素治疗。

结论

腹水及其相关并发症诊断和治疗方面的最新进展改善了这些晚期肝病表现患者的医疗管理及不良预后。早期诊断、充分治疗、注重并发症预防以及及时转诊进行肝移植仍然至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验